Rotavirus vaccine and diarrhea mortality: quantifying regional variation in effect size

BMC Public Health

Table 1 Countdown to 2015 and GAVI eligible countries by under 5 mortality rate and region for use in applying rotavirus vaccine effect size

Region/Country	< 5 Mortality Rate	Region/Country	< 5 Mortality Rate
Developed		Sub-Saharan Africa
Cuba	6	Eritrea	55
Ukraine	15	Botswana	57
Armenia	22	Madagascar	57
Moldova	17	South Africa	62
Low mortality Asia and North Africa		Ghana	68
China	19	Gabon	69
Sri Lanka	15	Swaziland	73
Egypt	21	Sao Tome and Principe	78
Vietnam	23	Lesotho	82
Latin America		Kenya	84
Mexico	17	Zimbabwe	86
Brazil	21	Djibouti	93
Peru	21	Senegal	93
Nicaragua	25	Togo	96
Honduras	29	Comoros	102
Guyana	35	Gambia	102
Guatemala	40	Ethiopia	104
Bolivia	50	Tanzania	105
Haiti	86	Sudan	108
High mortality Asia		Liberia	110
Georgia	29	Malawi	110
Mongolia	29	Rwanda	111
DPR Korea	33	Cote d'Ivoire	115
Philippines	33	Mauritania	115
Azerbaijan	34	Benin	117
Uzbekistan	35	Congo	125
Solomon Islands	36	Uganda	127
Kyrgyzstan	37	Nigeria	138
Morocco	37	Mozambique	139
Indonesia	39	Guinea	140
Iraq	44	Zambia	141
Turkmenistan	45	Equitorial Guinea	147
Kiribati	46	Cameroon	150
Nepal	48	Niger	156
Bangladesh	52	Angola	161
Timor Leste	56	Burundi	165
Laos	58	Burkina Faso	166
Tajikistan	61	CAR	168
India	66	Somalia	179
Papua new guinea	66	Mali	191
Yemen	66	Sierra Leone	191
Myanmar	71	Guinea-Bissau	192
Bhutan	79	DR Congo	193
Pakistan	85	Chad	208
Cambodia	87
Afghanistan	192

ISSN: 1471-2458